Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 1.051
Filter
1.
Water Res ; 246: 120737, 2023 Nov 01.
Article in English | MEDLINE | ID: mdl-37857011

ABSTRACT

Reliable and cost-effective methods for monitoring microbial activity are critical for process control in wastewater treatment plants. The dehydrogenase activity (DHA) test has been recognized as an efficient measure of biological activity due to its simplicity and broad applicability. Nevertheless, the existing DHA test methods suffer from imperfections and are difficult to implement as routine monitoring techniques. In this work, an accurate and cost-effective modified DHA approach was developed and the procedure for the DHA test was critically evaluated with respect to the standard construction, sample pretreatment, incubation and extraction conditions. The feasibility of the modified DHA test was demonstrated by comparison with the oxygen uptake rate and adenosine triphosphate in a sequencing batch reactor. The sensitivities of the two typical tetrazolium salts to toxicant inhibition by heavy metals and antibiotics were compared, revealing that 2,3,5-triphenyltetrazolium chloride (TTC) exhibited a higher sensitivity. Furthermore, the sensitivity mechanism of the two DHA tests was elucidated through electrochemical experiments, theoretical analysis and molecular simulations. Both tetrazolium salts were found to be effective artificial electron acceptors due to their low redox potentials. Molecular docking simulations revealed that TTC could outperform other tetrazolium salts in accepting electrons and hydrogens from dehydrogenase. Overall, the modified DHA approach presents an accurate and cost-effective way to measure microbial activity, making it a practical tool for wastewater treatment plants.


Subject(s)
Anti-Bacterial Agents , Water Purification , Molecular Docking Simulation , Tetrazolium Salts/chemistry , Tetrazolium Salts/pharmacology , Anti-Bacterial Agents/pharmacology , Oxidoreductases
2.
J Biomed Mater Res B Appl Biomater ; 111(2): 241-260, 2023 02.
Article in English | MEDLINE | ID: mdl-36054531

ABSTRACT

In vitro cytotoxicity assessment is indispensable in developing new biodegradable implant materials. Zn, which demonstrates an ideal corrosion rate between Mg- and Fe-based alloys, has been reported to have excellent in vivo biocompatibility. Therefore, modifications aimed at improving Zn's mechanical properties should not degrade its biological response. As sufficient strength, ductility and corrosion behavior required of load-bearing implants has been obtained in plastically deformed Zn-3Ag-0.5Mg, the effect of simultaneous Ag and Mg additions on in vitro cytocompatibility and antibacterial properties was studied, in relation to Zn and Zn-3Ag. Direct cell culture on samples and indirect extract-based tests showed almost no significant differences between the tested Zn-based materials. The diluted extracts of Zn, Zn-3Ag, and Zn-3Ag-0.5Mg showed no cytotoxicity toward MG-63 cells at a concentration of ≤12.5%. The cytotoxic effect was observed only at high Zn2+ ion concentrations and when in direct contact with metallic samples. The highest LD50 (lethal dose killing 50% of cells) of 13.4 mg/L of Zn2+ ions were determined for the Zn-3Ag-0.5Mg. Similar antibacterial activity against Escherichia coli and Staphylococcus aureus was observed for Zn and Zn alloys, so the effect is attributed mainly to the released Zn2+ ions exhibiting bactericidal properties. Most importantly, our experiments indicated the limitations of water-soluble tetrazolium salt-based cytotoxicity assays for direct tests on Zn-based materials. The discrepancies between the WST-8 assay and SEM observations are attributed to the interference of Zn2+ ions with tetrazolium salt, therefore favoring its transformation into formazan, giving false cell viability quantitative results.


Subject(s)
Absorbable Implants , Alloys , Alloys/pharmacology , Materials Testing , Cell Line , Corrosion , Anti-Bacterial Agents/pharmacology , Escherichia coli , Ions , Zinc/pharmacology , Tetrazolium Salts/pharmacology , Biocompatible Materials/pharmacology
3.
Invest Ophthalmol Vis Sci ; 63(10): 19, 2022 09 01.
Article in English | MEDLINE | ID: mdl-36169947

ABSTRACT

Purpose: Sirtuin1 (SIRT1) as a hot therapeutic target for oxidative stress-associated diseases that has been extensively studied. This study aimed to determine the changes in SIRT1 expression in particulate matter (PM)-induced corneal and conjunctival epithelial cell damage and explore potential drugs to reduce PM-associated ocular surface injury. Methods: Immortalized human corneal epithelial cells (HCECs) and human conjunctival epithelial cells (HCjECs) were exposed to an ambient PM sample. Cytotoxicity was evaluated by water-soluble tetrazolium salt-8 assay. SIRT1 expression was measured by Western blot analysis. Reactive oxygen species (ROS) production, cell apoptosis, mitochondrial function, and cell senescence were assessed by using 2',7'-dichlorofluorescein diacetate assay, annexin V apoptosis assay, tetramethylrhodamine ethyl ester assay, and senescence ß-galactosidase staining, respectively. Results: PM-induced cytotoxicity of HCECs and HCjECs occurred in a dose-dependent manner. Increased ROS production, as well as decreased SIRT1 expression, were observed in HCECs and HCjECs after 200 µg/mL PM exposure. In addition, PM induced oxidative stress-mediated cellular damage, including cell apoptosis, mitochondrial damage, and cell senescence. Interestingly, SRT1720, a SIRT1 activator, increased SIRT1 expression and decreased ROS production and attenuated PM-induced cell damage in HCECs and HCjECs. Conclusions: This study determined that SIRT1 was involved in PM-induced oxidative stress in HCECs and HCjECs and found that ROS overproduction may a key factor in PM-induced SIRT1 downregulation. The SIRT1 activator, SRT1720, can effectively upregulate SIRT1 expression and inhibit ROS production, thereby reversing PM-induced cell damage. This study provides a new potential target for clinical treatment of PM-associated ocular surface diseases.


Subject(s)
Particulate Matter , Sirtuin 1 , Annexin A5/metabolism , Apoptosis , Epithelial Cells/metabolism , Esters/metabolism , Esters/pharmacology , Humans , Oxidative Stress , Particulate Matter/toxicity , Reactive Oxygen Species/metabolism , Sirtuin 1/metabolism , Tetrazolium Salts/metabolism , Tetrazolium Salts/pharmacology , Water/metabolism , beta-Galactosidase/metabolism
4.
Eur Endod J ; 6(3): 303-308, 2021 12.
Article in English | MEDLINE | ID: mdl-34967344

ABSTRACT

OBJECTIVE: This study aimed to assess the cytotoxicity and genotoxicity of triple antibiotic paste, double antibiotic paste and calcium hydroxide medicaments on human stem cells of the apical papilla. METHODS: In this experimental study, stem cells were isolated from the apical papilla and cultured. They are treated with different concentrations 0.1, 0.5, 1, 10 and 100 mg/ml of medicaments for 24, 48 and 72 hours. The cytotoxicity and genotoxicity of the medicaments were determined using methyl thiazolyl tetrazolium assay and Comet test, respectively. RESULTS: Results showed all tested concentrations of the calcium hydroxide had no significant effect on stem cells at any time point. Triple antibiotic paste showed cytotoxicity in 10 and 100 mg/mL concentrations at all-time points and in 1, 10 and 100 mg/ml concentrations at 72 hours. In addition, its genotoxicity was significantly higher than that of other groups (P<0.05). Double antibiotic paste showed cytotoxic effects only in 100 mg/ml concentration at 24 hours and 10 and 100 mg/ml concentrations at 48 and 72 hours. And also, its genotoxicity in these concentrations was significantly higher than that of control and calcium hydroxide groups (P<0.05). CONCLUSION: In contrast to calcium hydroxide, triple antibiotic paste and double antibiotic paste, especially in their higher concentrations, induced cytotoxicity and genotoxicity on human stem cells of the apical papilla.


Subject(s)
Anti-Bacterial Agents , Calcium Hydroxide , Anti-Bacterial Agents/toxicity , Calcium Hydroxide/toxicity , DNA Damage , Humans , Stem Cells , Tetrazolium Salts/pharmacology
5.
Microbiol Spectr ; 9(3): e0163721, 2021 12 22.
Article in English | MEDLINE | ID: mdl-34937171

ABSTRACT

The MTT assay, based on the enzymatic reduction of the water-soluble, yellowish tetrazolium salt 3-(4,5-dimethylthiazol)-2,5-diphenyl-tetrazolium bromide (MTT) to purple formazan, is commonly used for assessment of cell viability and proliferation. Accurate performance by the MTT assay depends on complete solubilization of cells and formazan and stability of the colored solution. Comparison of different solubilization solutions revealed that dimethylformamide (DMF) and dimethyl sulfoxide (DMSO), buffered with ammonia buffer, pH 10, and containing 5% SDS, produced the best results. These two solvents provided rapid and complete solubilization of formazan and cells, with minimal background absorbance at 700 nm, good reproducibility (low interassay coefficient of variation), high sensitivity, and color stability for at least 24 h. A linear relationship between viable-cell number and formazan absorbance was preserved for cell densities up to ∼1 × 109 cells/mL for Gram-negative and Gram-positive microorganisms. Since MTT can be reduced by medium components in the absence of cells, blanks containing all medium components but no cells should be run simultaneously. Measurements at two wavelengths, one corresponding to absorption peak of formazan (570 nm) and a background absorbance far from the peak (700 nm), are necessary to avoid artifacts due to incomplete solubilization and turbidity. IMPORTANCE Reduction of the water-soluble tetrazolium salt 3-(4,5-dimethylthiazol)-2,5 diphenyl-tetrazolium bromide (MTT) to purple, water-insoluble formazan is commonly used for assessment of cell viability and proliferation. Spectrophotometric detection of formazan requires its solubilization. The solubilization solvent has a strong influence on data acquisition and often introduces artifacts, leading to misreading of results. This study offers a choice of solvents that minimize solubilization artifacts when the MTT test is applied to microbiological cultures.


Subject(s)
Bacteria/drug effects , Formazans/chemistry , Formazans/pharmacology , Tetrazolium Salts/chemistry , Tetrazolium Salts/pharmacology , Microbial Sensitivity Tests , Microbial Viability/drug effects , Reproducibility of Results , Solubility
6.
Sci Rep ; 11(1): 23189, 2021 11 30.
Article in English | MEDLINE | ID: mdl-34848742

ABSTRACT

The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor known to mediate toxic responses to dioxin. However, the role of the AhR in the regulation of cellular physiology has only recently been appreciated, including its ability to control cell cycle progression and apoptosis by unknown mechanisms. We hypothesized that the AhR enhances the activation of the AKT serine/threonine kinase (Akt) pathway to promote cell survival. Utilizing AhR knock-out (Ahr-/-) and wild-type (Ahr+/+) mouse lung fibroblasts (MLFs), we found that Ahr-/- MLFs have significantly higher basal Akt phosphorylation but that AhR did not affect Akt phosphorylation in MLFs exposed to growth factors or AhR ligands. Basal Akt phosphorylation was dependent on PI3K but was unaffected by changes in intracellular glutathione (GSH) or p85α. There was no significant decrease in cell viability in Ahr-/- MLFs treated with LY294002-a PI3K inhibitor-although LY294002 did attenuate MTT reduction, indicating an affect on mitochondrial function. Using a mass spectrometry (MS)-based approach, we identified several proteins that were differentially phosphorylated in the Ahr-/- MLFs compared to control cells, including proteins involved in the regulation of extracellular matrix (ECM), focal adhesion, cytoskeleton remodeling and mitochondrial function. In conclusion, Ahr ablation increased basal Akt phosphorylation in MLFs. Our results indicate that AhR may modulate the phosphorylation of a variety of novel proteins not previously identified as AhR targets, findings that help advance our understanding of the endogenous functions of AhR.


Subject(s)
Gene Expression Regulation , Lung/metabolism , Proto-Oncogene Proteins c-akt/biosynthesis , Receptors, Aryl Hydrocarbon/metabolism , Animals , Cell Survival , Cells, Cultured , Cytoskeleton , Fibroblasts/metabolism , Homeostasis , Intercellular Signaling Peptides and Proteins , Mass Spectrometry , Mice , Phosphorylation , Proteomics/methods , Smoke , Tetrazolium Salts/pharmacology , Thiazoles/pharmacology , Tobacco Products
7.
J Steroid Biochem Mol Biol ; 214: 105990, 2021 11.
Article in English | MEDLINE | ID: mdl-34478830

ABSTRACT

Gynaecological cancers are leading cause of death: breast cancer is the most frequently diagnosed type of malignancies, and cervical neoplasms rank fourth for both incidence and mortality among women worldwide. In one of our previous studies, favourable antiproliferative and antimetastatic properties of a newly synthesized androstane derivative, 17APAD have been demonstrated on breast cancer cell lines with different expression patterns of hormone receptors. The aim of the current study was to investigate the antitumoral potential of this molecule in cervical cancer cell lines, including SiHa cells positive for human papilloma virus (HPV) type 16 and HPV-negative C33A cells. 17APAD exerted pronounced growth-inhibition (with IC50 values ranging from 0.76 to 1.72 µM with considerable cancer selectivity), while cisplatin used as a reference agent yielded higher IC50 values (ranging from 3.69 to 12.43) and less selectivity, as evidenced by MTT assay. The proapoptotic effect and morphological changes induced by 17APAD were detected by Hoechst 33258-propidium iodide or Annexin V-Alexa488-propidium iodide fluorescent double staining methods, supplemented with a caspase-3 activity assay to identify the mechanism behind the programmed cell death induced by 17APAD. Additionally, significant and concentration-dependent elevation of the ratio of cells in the G2/M phase, on the expense of G0/G1 phase, was observed after 48 h of exposure to 17APAD. Besides its potent antiproliferative properties against both cervical cancer cell lines, 17APAD elicited a remarkable inhibition of cell migration and invasion as detected in wound-healing and Boyden chamber assays, respectively. The mechanisms of action underlying the effects of 17APAD on cell proliferation and motility were independent of androgenic activity, as demonstrated by the Yeast Androgen Screen method. Our results provide new evidence for the proapoptotic and anti-invasive properties of 17APAD, suggesting that it is worth of further research, as a promising prototype for designing novel anticancer agents.


Subject(s)
Androstadienes/chemistry , Neoplasm Invasiveness , Uterine Cervical Neoplasms/drug therapy , Androstadienes/pharmacology , Animals , Antineoplastic Agents/pharmacology , Apoptosis , Bisbenzimidazole , Caspase 3/metabolism , Cell Line, Tumor , Cell Movement , Cell Proliferation , Cisplatin/pharmacology , Female , HeLa Cells , Humans , Inhibitory Concentration 50 , Mice , NIH 3T3 Cells , Propidium , Tetrazolium Salts/pharmacology , Thiazoles/pharmacology , Wound Healing
8.
Int J Mol Sci ; 22(18)2021 Sep 18.
Article in English | MEDLINE | ID: mdl-34576274

ABSTRACT

Biotransformation of four bioactive phenolic constituents from licorice, namely licoisoflavanone (1), glycyrrhisoflavone (2), echinatin (3), and isobavachalcone (4), was performed by the selected fungal strain Aspergillus niger KCCM 60332, leading to the isolation of seventeen metabolites (5-21). Structures of the isolated compounds were determined on the basis of extensive spectroscopic methods, twelve of which (5-7, 10-17 and 19) have been previously undescribed. A series of reactions including hydroxylation, hydrogenation, epoxidation, hydrolysis, reduction, cyclization, and alkylation was observed in the biotransformation process. All compounds were tested for their cytotoxic activities against three different human cancer cell lines including A375P, MCF-7, and HT-29. Compounds 1 and 12 exhibited most considerable cytotoxic activities against all the cell lines investigated, while compounds 2 and 4 were moderately cytotoxic. These findings will contribute to expanding the chemical diversity of phenolic compounds, and compounds 1 and 12 may serve as leads for the development of potential cancer chemopreventive agents.


Subject(s)
Biotransformation , Glycyrrhiza/chemistry , Phenol/chemistry , Anticarcinogenic Agents/pharmacology , Antineoplastic Agents/chemistry , Aspergillus niger/metabolism , Cell Line, Tumor , Fermentation , Fungi/metabolism , HT29 Cells , Humans , Hydrolysis , Inhibitory Concentration 50 , MCF-7 Cells , Phenols , Plant Extracts , Plant Roots/drug effects , Powders , Rhizome/metabolism , Spectrophotometry , Tetrazolium Salts/pharmacology , Thiazoles/pharmacology
9.
Cancer Sci ; 112(10): 4037-4049, 2021 Oct.
Article in English | MEDLINE | ID: mdl-34309966

ABSTRACT

Immunotherapy with immune-checkpoint therapy has recently been used to treat oral squamous cell carcinomas (OSCCs). However, improvements in current immunotherapy are expected because response rates are limited. Transforming growth factor-ß (TGF-ß) creates an immunosuppressive tumor microenvironment (TME) by inducing the production of regulatory T-cells (Tregs) and cancer-associated fibroblasts and inhibiting the function of cytotoxic T-lymphocytes (CTLs) and natural killer cells. TGF-ß may be an important target in the development of novel cancer immunotherapies. In this study, we investigated the suppressive effect of TGF-ß on CTL function in vitro using OSCC cell lines and their specific CTLs. Moreover, TGFB1 mRNA expression and T-cell infiltration in 25 OSCC tissues were examined by in situ hybridization and multifluorescence immunohistochemistry. We found that TGF-ß suppressed the function of antigen-specific CTLs in the priming and effector phases in vitro. Additionally, TGF-ß inhibitor effectively restored the CTL function, and TGFB1 mRNA was primarily expressed in the tumor invasive front. Interestingly, we found a significant negative correlation between TGFB1 mRNA expression and the CD8+ T-cell/Treg ratio and between TGFB1 mRNA expression and the Ki-67 expression in CD8+ T-cells, indicating that TGF-ß also suppressed the function of CTLs in situ. Our findings suggest that the regulation of TGF-ß function restores the immunosuppressive TME to active status and is important for developing new immunotherapeutic strategies, such as a combination of immune-checkpoint inhibitors and TGF-ß inhibitors, for OSCCs.


Subject(s)
Immune Checkpoint Inhibitors/therapeutic use , Immunotherapy, Adoptive/methods , Mouth Neoplasms/therapy , Squamous Cell Carcinoma of Head and Neck/therapy , T-Lymphocytes, Cytotoxic/drug effects , Transforming Growth Factor beta1/antagonists & inhibitors , Tumor Microenvironment/immunology , Adult , Aged , Aged, 80 and over , CD8-Positive T-Lymphocytes/cytology , CD8-Positive T-Lymphocytes/immunology , Cancer-Associated Fibroblasts/cytology , Cancer-Associated Fibroblasts/immunology , Cell Line, Tumor , Cell Proliferation , Female , Humans , Interferon-gamma/analysis , Interferon-gamma/metabolism , Ki-67 Antigen/metabolism , Killer Cells, Natural/cytology , Killer Cells, Natural/immunology , Lymphocytes, Tumor-Infiltrating/cytology , Lymphocytes, Tumor-Infiltrating/immunology , Male , Middle Aged , Mouth Neoplasms/metabolism , RNA, Messenger/metabolism , Smad2 Protein/metabolism , Smad3 Protein/metabolism , Squamous Cell Carcinoma of Head and Neck/metabolism , T-Lymphocytes, Cytotoxic/cytology , T-Lymphocytes, Cytotoxic/immunology , T-Lymphocytes, Cytotoxic/metabolism , T-Lymphocytes, Regulatory/cytology , T-Lymphocytes, Regulatory/immunology , Tetrazolium Salts/pharmacology , Transforming Growth Factor beta/antagonists & inhibitors , Transforming Growth Factor beta/immunology , Transforming Growth Factor beta1/analysis , Transforming Growth Factor beta1/genetics , Transforming Growth Factor beta1/metabolism , Tumor Necrosis Factor-alpha/analysis , Tumor Necrosis Factor-alpha/metabolism , Young Adult
10.
Bioprocess Biosyst Eng ; 44(8): 1593-1616, 2021 Aug.
Article in English | MEDLINE | ID: mdl-34075470

ABSTRACT

Titanium dioxide nanoparticles exhibit good anticancer and antibacterial activities. They are known to be environmentally friendly, stable, less toxic, and have excellent biocompatibility nature. Due to these properties, they are well suited for biological applications particularly in biomedical applications such as drug delivery and cancer therapy. In this research article, three medicinal herbs namely, Plectranthus amboinicus (Karpooravalli), Phyllanthus niruri (Keezhanelli), and Euphorbia hirta (Amman Pacharisi), were used to modify the surface of the TiO2 nanoparticles. The synthesized nanoparticles were subjected to various characterization techniques. The samples are then subjected to MTT assay to determine cell viability. KB oral cancer cells are used for the determination of the anticancer nature of the pure and bio modified nanoparticles. It is observed that Plectranthus amboinicus-Phyllanthus niruri modified TiO2 nanoparticles exhibit excellent anticancer activities among other bio modified and pure samples. The samples are then examined for antibacterial activities against three Gram-negative bacterial strains namely, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and two Gram-positive bacterial strains namely, Staphylococcus aureus and Streptococcus mutans, respectively. Among the modified and pure samples, Plectranthus amboinicus showed good antibacterial activity against Gram-positive and Gram-negative bacteria. In the Flow cytometry analysis, the generation of p53 protein expression from Plectranthus amboinicus-Phyllanthus niruri modified TiO2 nano herbal particles shows the anti-cancerous nature of the sample. Then to determine the toxic nature of the Plectranthus amboinicus-Phyllanthus niruri modified TiO2 nano herbal particles against normal cells, the NPs were subjected to MTT assay against normal L929 cells, and it was found to be safer and less toxic towards the normal cells.


Subject(s)
Euphorbia/metabolism , Phyllanthus/metabolism , Plectranthus/metabolism , Titanium/chemistry , Agar/chemistry , Animals , Anti-Bacterial Agents/pharmacology , Antineoplastic Agents/pharmacology , Cell Line , Cell Survival , HEK293 Cells , Humans , Hydrogen-Ion Concentration , Metal Nanoparticles/chemistry , Mice , Microbial Sensitivity Tests , Models, Chemical , Nanotechnology/methods , Plant Extracts , Plant Leaves , Plant Preparations/pharmacology , Powders , Spectrophotometry, Ultraviolet , Spectroscopy, Fourier Transform Infrared , Tetrazolium Salts/pharmacology , Thiazoles/pharmacology , X-Ray Diffraction
11.
Cells ; 10(5)2021 04 26.
Article in English | MEDLINE | ID: mdl-33925786

ABSTRACT

Inflammation-mediated skeletal muscle wasting occurs in patients with sepsis and cancer cachexia. Both conditions severely affect patient morbidity and mortality. Lithium chloride has previously been shown to enhance myogenesis and prevent certain forms of muscular dystrophy. However, to our knowledge, the effect of lithium chloride treatment on sepsis-induced muscle atrophy and cancer cachexia has not yet been investigated. In this study, we aimed to examine the effects of lithium chloride using in vitro and in vivo models of cancer cachexia and sepsis. Lithium chloride prevented wasting in myotubes cultured with cancer cell-conditioned media, maintained the expression of the muscle fiber contractile protein, myosin heavy chain 2, and inhibited the upregulation of the E3 ubiquitin ligase, Atrogin-1. In addition, it inhibited the upregulation of inflammation-associated cytokines in macrophages treated with lipopolysaccharide. In the animal model of sepsis, lithium chloride treatment improved body weight, increased muscle mass, preserved the survival of larger fibers, and decreased the expression of muscle-wasting effector genes. In a model of cancer cachexia, lithium chloride increased muscle mass, enhanced muscle strength, and increased fiber cross-sectional area, with no significant effect on tumor mass. These results indicate that lithium chloride exerts therapeutic effects on inflammation-mediated skeletal muscle wasting, such as sepsis-induced muscle atrophy and cancer cachexia.


Subject(s)
Cachexia/prevention & control , Lithium Chloride/pharmacology , Muscle, Skeletal/pathology , Muscular Atrophy/pathology , Neoplasms/drug therapy , Sepsis/drug therapy , Sepsis/prevention & control , Animals , Body Weight , Cell Differentiation , Cell Proliferation , Culture Media, Conditioned , Glycogen Synthase Kinase 3 beta/biosynthesis , Inflammation , Lipopolysaccharides , Male , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Muscle Contraction , Muscle Fibers, Skeletal/drug effects , Muscle Proteins/biosynthesis , Muscle, Skeletal/metabolism , Neoplasms/complications , RAW 264.7 Cells , RNA, Small Interfering/metabolism , SKP Cullin F-Box Protein Ligases/biosynthesis , Tetrazolium Salts/pharmacology , Thiazoles/pharmacology
12.
Carbohydr Polym ; 258: 117659, 2021 Apr 15.
Article in English | MEDLINE | ID: mdl-33593545

ABSTRACT

Chemically modified biopolymers derived nanomaterials have shown great potential in drug delivery and live-cell imaging. We have developed two materials, doxorubicin-loaded chitosan-gold nanoparticles and beads, both embedded with functionalized silk fibroin. Nanoparticles with size 8 ± 3 nm were synthesized using chitosan as reducing and stabilizing agent. Beads with 900-1000 µm size were formulated by the ionic gelation technique. Both the materials were coated with functionalized silk fibroin for targeted and sustained drug release properties. The coated materials showed retarded drug release compared to the uncoated ones. The cytotoxicity was assessed in HeLa cell lines, which demonstrated a maximum dose-dependent decrease in cell viability for the cells treated with folate conjugated silk fibroin coated nanoparticles. The live-cell imaging of the nanoparticles unveiled the increased cellular uptake of the coated materials by seven folds than the uncoated ones. Thus, functionalized silk coated materials can be effective drug delivery tools for targeted and sustained drug release.


Subject(s)
Antineoplastic Agents/pharmacology , Chitosan/chemistry , Gold/chemistry , Metal Nanoparticles/chemistry , Microspheres , Silk/metabolism , Cell Survival , Delayed-Action Preparations/chemistry , Doxorubicin/pharmacokinetics , Drug Carriers , Drug Delivery Systems , Drug Liberation , Fibroins/chemistry , Fluorescein , Folic Acid/chemistry , Green Chemistry Technology , HeLa Cells , Humans , Hydrogels/chemistry , Microscopy, Fluorescence , Molecular Weight , Particle Size , Spectroscopy, Fourier Transform Infrared , Surface Properties , Tetrazolium Salts/pharmacology , Thiazoles/pharmacology
13.
Kaohsiung J Med Sci ; 37(7): 594-603, 2021 Jul.
Article in English | MEDLINE | ID: mdl-33611829

ABSTRACT

Chronic obstructive pulmonary disease (COPD) is a chronic respiratory disorder. Although numerous studies on COPD have been conducted, therapeutic strategies for COPD are limited, and its pathological mechanism is still unclear. The present study aimed to explore the role of DNA methyltransferase 3a (DNMT3a) in dendritic cells (DCs) and the possible role of the Th-17/Treg cell balance in COPD. Immature DCs (iDCs) were induced and cocultured with CD4+ T cells. An in vitro COPD model was established by treatment with cigarette smoke extract (CSE). DNMT3a or allograft inflammatory factor 1 (AIF1) and c-Jun N-terminal kinase (JNK) were inhibited and overexpressed, respectively, by transfection with sh-DNMT3a or sh-AIF1 and JNK overexpression plasmids. The 3- (4,5-cimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay was used to measure cell viability. The Th17/Treg cell ratio was determined by flow cytometry. The expression levels of DNMT3a, c-Jun and AIF1 were measured using RT-qPCR or western blotting. Chromatin immunoprecipitation (CHIP) was used to confirm the interaction between c-Jun and the AIF1 promoter region. CSE stimulation promoted the expression of DNMT3a, and AIF1, and the ratio of p-c-Jun/c-Jun in iDCs. Besides, the iDC-mediated differentiation of Th17 cells was in a dose-dependent manner. However, knockdown of DNMT3a or AIF1 reversed the above effects caused by CSE. Inhibition of c-Jun signaling by treatment with the JNK inhibitor SP600125 also suppressed the iDC-mediated differentiation of Th17 cells, which was promoted by CSE. CHIP analysis showed that c-Jun could bind to the promoter region of AIF1. DNMT3a could regulate the iDC-mediated Th17/Treg balance by regulating the c-Jun/AIF1 axis.


Subject(s)
Calcium-Binding Proteins/metabolism , DNA Methyltransferase 3A/metabolism , Microfilament Proteins/metabolism , Proto-Oncogene Proteins c-jun/metabolism , Smoke , Smoking/adverse effects , T-Lymphocytes, Regulatory/metabolism , Allografts , Animals , Anthracenes/pharmacology , CD4-Positive T-Lymphocytes/cytology , Cell Differentiation , Cells, Cultured , Dendritic Cells/metabolism , Disease Models, Animal , Enzyme Inhibitors/pharmacology , Male , Mice , Mice, Inbred BALB C , Pulmonary Disease, Chronic Obstructive/genetics , Signal Transduction , Tetrazolium Salts/pharmacology , Th17 Cells/metabolism , Thiazoles/pharmacology
14.
Kaohsiung J Med Sci ; 37(6): 505-512, 2021 Jun.
Article in English | MEDLINE | ID: mdl-33559348

ABSTRACT

Multidrug resistance (MDR) of chemotherapy is one of the significant concerns in cancer therapy. Here in our study, cisplatin (DDP) and oleanolic acid (OA) were co-loaded in mesoporous silica nanoparticles (Nsi) to construct DDP/OA-Nsi and solve the DDP-resistance in lung cancer therapy. The cytotoxicity and apoptosis assays demonstrated that in DDP-resistant A549/DDP cells, the cytotoxicity of DDP/OA-Nsi was significantly higher than that of free DDP or DDP single delivery system (DDP-Nsi). The intracellular drug accumulation study revealed that the intracellular DDP concentration in the DDP/OA-Nsi group was also higher than that in free DDP and DDP-Nsi groups. In the A549/DDP xenograft tumor model, DDP/OA-Nsi showed the best anticancer effect. In summary, DDP/OA-Nsi was a promising drug delivery system to solve MDR in lung cancer therapy.


Subject(s)
Apoptosis , Cisplatin/administration & dosage , Drug Delivery Systems , Drug Resistance, Multiple , Drug Resistance, Neoplasm , Lung Neoplasms/metabolism , Nanoparticles/administration & dosage , Oleanolic Acid/administration & dosage , Silicon Dioxide/chemistry , A549 Cells , Animals , Antineoplastic Agents/pharmacology , Cell Proliferation/drug effects , Humans , Lung Neoplasms/pathology , Male , Mice , Mice, Inbred BALB C , Mice, Nude , Neoplasm Transplantation , Tetrazolium Salts/pharmacology , Thiazoles/pharmacology
15.
Sci Rep ; 11(1): 973, 2021 01 13.
Article in English | MEDLINE | ID: mdl-33441658

ABSTRACT

The objectives of the in vitro study were: (1) to investigate the effect of combining L-arginine (Arg) and NaF on the growth of Lactobacillus rhamnosus GG (LRG); and (2) to identify an optimum synergistic concentration for the synbiotic (Arg + LRG)-fluoride (SF) therapy. 1% Arg + 2000-ppm NaF (A-SF) and 2% Arg + 2000-ppm NaF (B-SF) demonstrated antagonism against LRG (FIC > 4.0). Both XTT (2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide) and WST-8 (2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt) assays showed that A-SF and B-SF enhanced the growth of LRG when compared to 2000-ppm NaF and LRG control. Colony forming units, bacterial weight, and biofilm thickness of A-SF and B-SF were significantly higher than 2000-ppm NaF and LRG control. Biofilm imaging depicted that 2000-ppm NaF inhibited biofilm formation; while 1%/2% Arg, A-SF, and B-SF increased biofilm growth of LRG. Lactic acid formation was the lowest for 2000-ppm NaF, followed by A-SF and then B-SF. The SF buffer potential after 24 h was the highest for B-SF, and then A-SF. Biofilm pH for B-SF was closest to neutral. Fluoride, Arg and LRG bioavailability remained unaffected in B-SF. The relative gene expression for arcA, argG, and argH was significantly higher for B-SF than the respective controls. In conclusion, combining 2% Arg, 2000-ppm NaF, and LRG provides an optimum synbiotic-fluoride synergism.


Subject(s)
Arginine/pharmacology , Biofilms/drug effects , Fluorides/pharmacology , Lacticaseibacillus rhamnosus/drug effects , Sodium Fluoride/pharmacology , Cariostatic Agents/pharmacology , Gene Expression Regulation, Bacterial/drug effects , Lacticaseibacillus rhamnosus/genetics , Synbiotics , Tetrazolium Salts/pharmacology
16.
Mol Cell Biochem ; 476(3): 1455-1465, 2021 Mar.
Article in English | MEDLINE | ID: mdl-33389496

ABSTRACT

Melanoma ranks second in aggressive tumors, and the occurrence of metastasis in melanoma results in a persistent drop in the survival rate of patients. Therefore, it is very necessary to find a novel therapeutic method for treating melanoma. It has been reported that lncRNA XIST could promote the tumorigenesis of melanoma. However, the mechanism by which lncRNA XIST regulates the progression of melanoma remains unclear. The proliferation of A375 cells was measured by clonal formation. Cell viability was detected by MTT assay. Flow cytometry was performed to detect cell apoptosis and cycle. The level of GINS2, miR-23a-3p, and lncRNA XIST was investigated by qRT-PCR. Protein level was detected by Western blot, and the correctness of prediction results was confirmed by Dual luciferase. In present study, GINS2 and lncRNA XIST were overexpressed in melanoma, while miR-23a-3p was downregulated. Silencing of GINS2 or overexpression of miR-23a-3p reversed cell growth and promoted apoptosis in A375 cells. Mechanically, miR-23a-3p directly targeted GINS2, and XIST regulated GINS2 level though mediated miR-23a-3p. Moreover, XIST exerted its function on cell proliferation, cell viability, and promoted the cell apoptosis of A375 cells though miR-23a-3p/GINS2 axis. LncRNA XIST significantly promoted the tumorigenesis of melanoma via sponging miR-23a-3p and indirectly targeting GINS2, which can be a potential new target for treating melanoma.


Subject(s)
Apoptosis , Chromosomal Proteins, Non-Histone/biosynthesis , Gene Expression Regulation, Neoplastic , MicroRNAs/metabolism , RNA, Long Noncoding/genetics , Cell Cycle , Cell Line, Tumor , Cell Movement , Cell Proliferation , Cell Survival , Down-Regulation , Gene Expression Regulation , Gene Silencing , HEK293 Cells , Humans , Melanocytes/metabolism , Melanoma/metabolism , MicroRNAs/genetics , Signal Transduction , Tetrazolium Salts/pharmacology , Thiazoles/pharmacology
17.
Assay Drug Dev Technol ; 19(3): 184-190, 2021 04.
Article in English | MEDLINE | ID: mdl-33471568

ABSTRACT

The 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay is one of the most commonly used tests of cell proliferation. Hydralazine has been reported to interfere with the performance of the MTS assay when used on adherent cells. This study aimed to investigate whether hydralazine interferes with the performance of the MTS assay on suspended cells. THP-1 (a monocytic leukemia cell line) cells were cultured in the presence or absence of hydralazine (0, 10, 50, 100, and 500 µM) for 2 or 24 h. Cell numbers were analyzed using the MTS, trypan blue exclusion, or microscopic assays. A modified version of the standard MTS assay was established by centrifuging the cells and replacing the test medium with fresh culture medium immediately before the addition of the MTS reagent. Culture of THP-1 cells with hydralazine at concentrations of 50, 100, and 500 µM for 2 h increased absorbance (p < 0.001) in the standard MTS assay, whereas both the trypan blue exclusion assay and microscopy suggested no change in cell numbers. Culture of THP-1 cells with 100 and 500 µm hydralazine for 24 h increased absorbance (p < 0.05) in the standard MTS assay; however, trypan blue exclusion and microscopy suggested a decrease in cell numbers. In a cell-free system, hydralazine (100 and 500 µM) increased absorbance in a time- and concentration-dependent manner. The modified MTS assay produced results consistent with trypan blue exclusion and microscopy using THP-1 cells. In addition, the modified MTS assay produced reliable results when K562 and Jurkat cells were incubated with hydralazine or ß-mercaptoethanol (ßME). In conclusion, a simple modification of the standard MTS assay overcame the interference of hydralazine and ßME when assessing suspended cells.


Subject(s)
Cell Proliferation/drug effects , Hydralazine/pharmacology , Mercaptoethanol/pharmacology , Tetrazolium Salts/pharmacology , Thiazoles/pharmacology , Cell-Free System/drug effects , Dose-Response Relationship, Drug , Humans , Jurkat Cells/drug effects , Microscopy , THP-1 Cells/drug effects
18.
Pak J Biol Sci ; 23(9): 1184-1192, 2020 Jan.
Article in English | MEDLINE | ID: mdl-32981249

ABSTRACT

BACKGROUND AND OBJECTIVE: Hyptis suaveolens is an aromatic plant used in traditional medicine in Burkina Faso for management of various diseases including wounds and inflammatory diseases. Thus, the objective of this work was to characterize the chemical composition, antioxidant and cytotoxic activity of Essential Oil (EO) of H. suaveolens from Burkina Faso on cultured cancer cells. MATERIALS AND METHODS: The chemical composition of EO was determined by GC/FID and GC/MS analysis and the antioxidant activity was evaluated through inhibition of DPPH radicals and ABTS +• radical cations. The cytotoxic activity in prostate cancer cells (LNCaP) and cervical cancer cells (HeLa) of EO was evaluated by MTT assay and effect on cells cycle by flow cytometry analysis. RESULTS: A total of 58 compounds were identified in the EO of H. suaveolens of which the major compounds identified are Sabinene 14.03%, ß-Pinene 5.92%, Limonene 4.40%, Eucalyptol 12.78%, Trans-Oxide of Linalol 5.43%, ß-Caryophyllene 11.27%, Germacrene-D 3.04% and Bicyclogermacrene 8.08%. The EO of H. suaveolens showed antioxidant activity and concentration dependent antiproliferative activities with G0/G1 arrest on LNCaP and HeLa cells. CONCLUSIONS: This work help to justify some uses of H. suaveolens in traditional medicine in Burkina Faso and also, presents a promising new application for the essential oil of H. suaveolens in prostate and cervical cancer research.


Subject(s)
Antioxidants/pharmacology , Hyptis/metabolism , Prostatic Neoplasms/metabolism , Uterine Cervical Neoplasms/metabolism , Antioxidants/chemistry , Burkina Faso , Cations , Cell Line, Tumor , Female , Flow Cytometry , Free Radicals , Gas Chromatography-Mass Spectrometry , HeLa Cells , Humans , In Vitro Techniques , Inhibitory Concentration 50 , Male , Monoterpenes , Oils, Volatile/pharmacology , Plant Extracts/pharmacology , Sesquiterpenes , Tetrazolium Salts/pharmacology , Thiazoles/pharmacology
19.
Assay Drug Dev Technol ; 18(8): 379-384, 2020.
Article in English | MEDLINE | ID: mdl-32907338

ABSTRACT

The MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium] assay is one of the most commonly used assays to assess cell proliferation and cytotoxicity, but is subject to interference by testing compounds. Hydralazine, an antihypertensive drug, is commonly investigated in multiple fields such as heart failure, cancer, and blood pressure research. This study reported interference of the MTS assay by hydralazine and a simple modification overcoming this interference. Vascular smooth muscle cells were cultured in the presence or absence of hydralazine (0, 10, 50,100, and 500 µM) for 2 or 24 h. Cell numbers were analyzed using MTS, trypan blue exclusion, or microscopic assays. A modified version of the standard MTS assay was established, in which an additional step was added replacing the test medium, containing hydralazine, with fresh culture medium immediately before the addition of the MTS reagent. Culture with hydralazine at concentrations of 50, 100, and 500 µM for 2 h increased absorbance (p < 0.05) in the standard MTS assay, whereas microscopy suggested no change in cell numbers. Culture with 500 µm hydralazine for 24 h increased absorbance (p < 0.05) in the standard MTS assay, however, trypan blue exclusion and microscopy suggested a decrease in cell numbers. In a cell-free system, hydralazine (≥10 µM) increased absorbance in a concentration-dependent manner. The modified MTS assay produced results consistent with trypan blue exclusion and microscopy. In conclusion, a simple modification of the standard MTS assay overcame the interference of hydralazine and may be useful to avoid interference from other tested compounds.


Subject(s)
Hydralazine/antagonists & inhibitors , Tetrazolium Salts/pharmacology , Thiazoles/pharmacology , Animals , Cell Proliferation/drug effects , Cells, Cultured , Hydralazine/pharmacology , Mice
20.
Int J Mol Sci ; 21(11)2020 May 31.
Article in English | MEDLINE | ID: mdl-32486510

ABSTRACT

Copper-containing coordination compounds attract wide attention due to the redox activity and biogenicity of copper ions, providing multiple pathways of biological activity. The pharmacological properties of metal complexes can be fine-tuned by varying the nature of the ligand and donor atoms. Copper-containing coordination compounds are effective antitumor agents, constituting a less expensive and safer alternative to classical platinum-containing chemotherapy, and are also effective as antimicrobial, antituberculosis, antimalarial, antifugal, and anti-inflammatory drugs. 64Сu-labeled coordination compounds are promising PET imaging agents for diagnosing malignant pathologies, including head and neck cancer, as well as the hallmark of Alzheimer's disease amyloid-ß (Aß). In this review article, we summarize different strategies for possible use of coordination compounds in the treatment and diagnosis of various diseases, and also various studies of the mechanisms of antitumor and antimicrobial action.


Subject(s)
Amyloid beta-Peptides/chemistry , Biological Factors/chemistry , Copper/chemistry , Alzheimer Disease/drug therapy , Animals , Anti-Infective Agents/therapeutic use , Antineoplastic Agents/therapeutic use , Cell Line, Tumor , Drug Design , Drug Evaluation, Preclinical , Flow Cytometry , HEK293 Cells , Humans , Inhibitory Concentration 50 , Ions , Isotopes/chemistry , Ligands , MCF-7 Cells , Mycobacterium tuberculosis , Oxidation-Reduction , Positron-Emission Tomography , Spectrophotometry , Tetrazolium Salts/pharmacology , Thiazoles/pharmacology , Tuberculosis/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...